SEMINARS IN ONCOLOGY

SEMINARS IN ONCOLOGY Journal

publication venue for

Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction 2015
Incorporating Immunotherapy Into the Treatment of Non-Small Cell Lung Cancer: Practical Guidance for the Clinic 2015
Altered Fractionation Schedules in Radiation Treatment: A Review 2014
A 62-Year-Old Woman With Osteogenic Sarcoma in the Contralateral Breast 15 Years After Treatment for Breast Cancer 2013
The emergence of a unique population in non-small cell lung cancer: Systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy 2006
Chemotherapeutic issues in the management of unresectable stage III non-small cell lung cancer. 32:S18-S24. 2005
Combined modality trials in unresectable stage III non-small cell lung cancer: The cancer and leukemia group B experience. 32:S114-S118. 2005
Does more aggressive therapy improve outcomes in the treatment of unresectable stage III non-small cell lung cancer?. 32:S13-S17. 2005
Pemetrexed (Alimta) in small cell lung cancer. 32:S1-S4. 2005
The evolving role of pemetrexed (Alimta) in lung cancer. 32:S16-S22. 2005
Drug development in patients with advanced non-small cell lung cancer and poor performance status 2004
Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer. 31:8-12. 2004
Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: Preliminary data. 30:96-100. 2003
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer 1999
The current status of adjuvant chemotherapy for resected non-small cell lung cancer 1999
High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer. 1997
Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial. 1997

International Standard Serial Number (ISSN)

0093-7754

Electronic International Standard Serial Number (EISSN)

1532-8708

journal abbreviation

SEMIN ONCOL
Semin Oncol